{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,24]],"date-time":"2024-02-24T01:10:02Z","timestamp":1708737002139},"reference-count":53,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1016\/j.pnpbp.2008.03.008","type":"journal-article","created":{"date-parts":[[2008,3,21]],"date-time":"2008-03-21T14:49:39Z","timestamp":1206110979000},"page":"1214-1220","source":"Crossref","is-referenced-by-count":2,"title":["Increased hexosaminidase activity in antipsychotic-induced extrapyramidal side effects: Possible association with higher occurrence in bipolar disorder patients"],"prefix":"10.1016","volume":"32","author":[{"given":"Zeliha","family":"Tunca","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Halil","family":"Resmi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. Asuman","family":"Ozkara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00f6nenc","family":"Ciliv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Basak","family":"Celtikci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koksal","family":"Alptekin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aysegul","family":"Ozerdem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Berna Kivircik","family":"Akdede","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Burak","family":"Baykara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bilge","family":"Birsoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gul","family":"Ergor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2008.03.008_bib1","series-title":"American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders","year":"1994"},{"key":"10.1016\/j.pnpbp.2008.03.008_bib2","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0304-3940(83)90054-X","article-title":"Chronic ganglioside treatment counteracts the biochemical signs of dopamine receptor supersensitivity induced by chronic haloperidol treatment","volume":"40","author":"Agnati","year":"1983","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pnpbp.2008.03.008_bib3","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/BF02247487","article-title":"GM1 ganglioside attenuates the development of vacuous chewing movements induced by long-term haloperidol treatment of rats","volume":"4","author":"Andreassen","year":"1994","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pnpbp.2008.03.008_bib4","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0047-6374(75)90022-6","article-title":"Regional study of acid hydrolyses and lysosomal membrane properties in the normal human brain at various ages","volume":"4","author":"Brun","year":"1975","journal-title":"Mech Ageing Dev"},{"key":"10.1016\/j.pnpbp.2008.03.008_bib5","first-page":"25","article-title":"Pathophysiology of antipsychotic drug-induced movement disorders","volume":"65","author":"Casey","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.03.008_bib6","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0009-8981(99)00133-3","article-title":"Elevated-N-acetylhexosaminidase activity in focal dystonia fibroblasts","volume":"288","author":"Cavazzoni","year":"1999","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.pnpbp.2008.03.008_bib7","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0165-3806(98)00088-1","article-title":"Mosaic distribution of chondroitin and keratan sulphate in the developing rat striatum: possible involvement of proteoglycans in the organization of the nigrostriatal system","volume":"8","author":"Charvet","year":"1998","journal-title":"Brain Res Dev Brain Res"},{"key":"10.1016\/j.pnpbp.2008.03.008_bib52","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0009-8981(99)00133-3","article-title":"Elevated-N-acetylhexosaminidase activity in focal dystonia fibroblasts","author":"Costanzi","year":"1999","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.pnpbp.2008.03.008_bib8","series-title":"Drug Induced Moment Disorders","first-page":"41","article-title":"Drug induced Parkinsonism","author":"Friedman","year":"1992"},{"key":"10.1016\/j.pnpbp.2008.03.008_bib9","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.pnpbp.2005.10.014","article-title":"Extrapyramidal side effects with atypical neuroleptics in bipolar disorder","volume":"30","author":"Ghaemi","year":"2006","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.03.008_bib10","first-page":"22","article-title":"A cross-sectional study of parkinsonism and tardive dyskinesia in lithium-treated affective disordered patients","volume":"57","author":"Ghadirian","year":"1996","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.03.008_bib11","doi-asserted-by":"crossref","unstructured":"Ginzburg, L., Kacher, Y., Futerman, A.H., (2004). Seminars in cell and developmental biology; 15: 417-431","DOI":"10.1016\/j.semcdb.2004.03.003"},{"issue":"Suppl","key":"10.1016\/j.pnpbp.2008.03.008_bib12","first-page":"16","article-title":"Extrapyramidal side effects, tardive dyskinesia, and the concept of atypicality","volume":"61","author":"Glazer","year":"2000","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.03.008_bib13","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0014-4886(03)00223-1","article-title":"GM1 enhances dopaminergic markers in the brain of aged rats","volume":"183","author":"Goettl","year":"2003","journal-title":"Exp Neurol"},{"key":"10.1016\/j.pnpbp.2008.03.008_bib14","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1046\/j.1471-4159.1998.70041335.x","article-title":"GM1 ganglioside: in vivo and in vitro trophic actions on central neurotransmitter systems","volume":"70","author":"Hadjiconstantinou","year":"1998","journal-title":"J Neurochem"},{"key":"10.1016\/j.pnpbp.2008.03.008_bib15","first-page":"931","article-title":"Changes of brain gangliosides in the frontal cortex of rats chronically treated with amphetamine, clozapine, haloperidol and ethanol","volume":"50","author":"Haselhorst","year":"1991","journal-title":"Biomed Biochim Acta"},{"key":"10.1016\/j.pnpbp.2008.03.008_bib16","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s11940-007-0036-z","article-title":"Emergency treatment of movement disorders","volume":"9","author":"Hu","year":"2007","journal-title":"Curr Treat Options Neurol"},{"key":"10.1016\/j.pnpbp.2008.03.008_bib17","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1176\/jnp.5.1.30","article-title":"Neuropsychiatric aspects of adult Tay-Sachs disease: two case reports with several new findings","volume":"5","author":"Hurowitz","year":"1993","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"10.1016\/j.pnpbp.2008.03.008_bib18","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.pnpbp.2003.09.004","article-title":"Half a century of antipsychotics, and still a central role for dopamine D2 receptors","volume":"27","author":"Kapur","year":"2003","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.03.008_bib19","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1159\/000095113","article-title":"The role of dopamine receptors in the neurobehavioral syndrome provoked by activation of L-type calcium channels in rodents","volume":"28","author":"Kasim","year":"2006","journal-title":"Dev Neurosci"},{"key":"10.1016\/j.pnpbp.2008.03.008_bib20","series-title":"Drug Induced Moment Disorders","first-page":"85","article-title":"Neuroleptics and classic tardive dyskinesia","author":"Khot","year":"1992"},{"key":"10.1016\/j.pnpbp.2008.03.008_bib21","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pnpbp.2008.03.008_bib22","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/0006-2952(78)90435-5","article-title":"Lipidosis induced by amphiphilic cationic drugs","volume":"27","author":"Lullman","year":"1978","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pnpbp.2008.03.008_bib23","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/S0006-3223(97)00187-X","article-title":"Neuroleptic malignant syndrome with gagliosidosis type II","volume":"41","author":"Manor","year":"1997","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.03.008_bib24","series-title":"Disorders of Lipid Metabolism","author":"Marinetti","year":"1990"},{"key":"10.1016\/j.pnpbp.2008.03.008_bib25","first-page":"243","article-title":"Lack of major effects of ethanol, chlorpromazine, hexobarbital and haloperidol on brain gangliosides","volume":"37","author":"Miller-Podraza","year":"1990","journal-title":"Acta Biochim Pol"},{"key":"10.1016\/j.pnpbp.2008.03.008_bib26","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1176\/ajp.145.11.1455","article-title":"Higher frequency of neuroleptic-induced dystonia in mania than in schizophrenia","volume":"145","author":"Nasrallah","year":"1988","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.03.008_bib27","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/S0006-291X(87)80245-0","article-title":"Depletion of cellular B-hexosaminidase by imipramine is prevented by dexamehasone-implications for treating psychotic hexosaminidase A deficient patients","volume":"148","author":"Navon","year":"1987","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pnpbp.2008.03.008_bib28","series-title":"The gangliosidoses. The metabolic Basis of Inherited Disease","first-page":"945","author":"O'Brien","year":"1987"},{"key":"10.1016\/j.pnpbp.2008.03.008_bib29","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1176\/ajp.150.11.1753a","article-title":"Contraindications to the use of antipsychotic drugs","volume":"150","author":"Ovsiew","year":"1993","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.03.008_bib30","series-title":"A guide to the extrapyramidal side-effects of antipsychotic drugs","author":"Owens","year":"1999"},{"key":"10.1016\/j.pnpbp.2008.03.008_bib31","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0306-3623(98)00208-0","article-title":"Kinetic analysis of GM1 effects on haloperidol-induced dopaminergic supersensitivity","volume":"32","author":"Palermo-Neto","year":"1999","journal-title":"Gen Pharmacol"},{"key":"10.1016\/j.pnpbp.2008.03.008_bib32","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0014-2999(02)02727-9","article-title":"Ceramide-induced alterations in dopamine transporter function","volume":"1","author":"Riddle","year":"2003","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pnpbp.2008.03.008_bib33","first-page":"347","article-title":"Late-onset Tay-Sachs disease presenting as catatonic schizophrenia: diagnostic and treatment issues","volume":"56","author":"Rosebush","year":"1995","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.03.008_bib53","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1126\/science.1350379","article-title":"Recovery from experimental parkinsonism in primates with GM1 ganglioside treatment","author":"Schneider","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.pnpbp.2008.03.008_bib34","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1212\/WNL.50.6.1630","article-title":"Parkinson's disease: improved function with GM1 ganglioside treatment in a randomized placebo-controlled study","volume":"50","author":"Schneider","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.pnpbp.2008.03.008_bib35","first-page":"1193","article-title":"Haloperidol-induced behavioral supersensitivity is increased by monosialoganglioside treatment in rats without affecting spiroperidol-binding","volume":"271","author":"Schroder","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pnpbp.2008.03.008_bib36","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S0091-3057(97)00026-9","article-title":"The role of striatal glutamatergic system in haloperidol-induced dopamine receptor supersensitivity and effects of monosialoganglioside GM1","volume":"58","author":"Schroeder","year":"1997","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pnpbp.2008.03.008_bib37","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1046\/j.1471-4159.1994.62051852.x","article-title":"Growth of ectopic dendrites on cortical pyramidal neurons in neuronal storage diseases correlates with abnormal accumulation of G M2 ganglioside","volume":"62","author":"Siegel","year":"1994","journal-title":"J Neurochem"},{"issue":"Suppl 212","key":"10.1016\/j.pnpbp.2008.03.008_bib38","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1600-0447.1970.tb02066.x","article-title":"A rating scale for extrapyramidal side effects","author":"Simpson","year":"1970","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.pnpbp.2008.03.008_bib39","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0167-4889(95)00163-8","article-title":"Cell-specific regulation of the stably expressed serotonin 5-HT1A receptor and altered ganglioside synthesis","volume":"2","author":"Singh","year":"1996","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.pnpbp.2008.03.008_bib40","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1212\/01.wnl.0000233847.72349.b6","article-title":"Late-onset Tay-Sachs disease: adverse effects of medications and implications for treatment","volume":"67","author":"Shapiro","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.pnpbp.2008.03.008_bib41","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1177\/089198879400700408","article-title":"Changes in tardive dyskinesia symptoms in elderly patients treated with ganglioside GM1 or placebo","volume":"7","author":"Sommer","year":"1994","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"10.1016\/j.pnpbp.2008.03.008_bib42","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1192\/bjp.155.3.410","article-title":"Psychiatric features of adult G M2 gangliosidosis","volume":"155","author":"Streifler","year":"1989","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.03.008_bib43","series-title":"Methods in Enzymology","doi-asserted-by":"crossref","DOI":"10.1016\/0076-6879(87)38063-2","article-title":"Enzymatic diagnosis of sphingolipidosis","author":"Suzuki","year":"1987"},{"key":"10.1016\/j.pnpbp.2008.03.008_bib44","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/00005072-196801000-00002","article-title":"Morphological, histochemical and biochemical studies on a case of systemic late infantile lipidosis","volume":"27","author":"Suzuki","year":"1968","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.pnpbp.2008.03.008_bib45","series-title":"Antipsychotic agents. Current Psychotherapeutic Drugs","first-page":"121","author":"Tandon","year":"2005"},{"key":"10.1016\/j.pnpbp.2008.03.008_bib46","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2165\/00023210-200216010-00003","article-title":"Effects of newer antipsychotics on extrapyramidal function","volume":"16","author":"Tarsy","year":"2002","journal-title":"CNS Drugs"},{"key":"10.1016\/j.pnpbp.2008.03.008_bib47","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/j.1600-0447.1982.tb04506.x","article-title":"Urinary beta-hexosaminidase excretion in patients treated with lithium, thymoleptic and\/or neuroleptic drugs","volume":"66","author":"Thysell","year":"1982","journal-title":"Acta Psychiatr Scan"},{"key":"10.1016\/j.pnpbp.2008.03.008_bib48","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1016\/0024-3205(95)00224-T","article-title":"Effects of monosialoganglioside on dopaminergic supersensitivity","volume":"56","author":"Vital","year":"1995","journal-title":"Life Sci"},{"key":"10.1016\/j.pnpbp.2008.03.008_bib49","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1600-0447.1997.tb10153.x","article-title":"Tardive dyskinesia: who is at risk?","volume":"96","author":"van Os","year":"1997","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.pnpbp.2008.03.008_bib50","first-page":"689","article-title":"Urinary beta-hexosaminidase activity as a marker for monitoring of sobriety","volume":"29","author":"Wehr","year":"1995","journal-title":"Psychiatr Pol"},{"key":"10.1016\/j.pnpbp.2008.03.008_bib51","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1159\/000026644","article-title":"Clinical manifestations of psychiatric patients who are carriers of Tay Sachs Disease. Possible role of psychotropic drugs","volume":"41","author":"Zelnik","year":"2000","journal-title":"Neuropsychobiology"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584608000869?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584608000869?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,2,24]],"date-time":"2024-02-24T00:49:55Z","timestamp":1708735795000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584608000869"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7]]},"references-count":53,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["S0278584608000869"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2008.03.008","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2008,7]]}}}